Constellation Pharmaceuticals

OrganizationROR

Trials

  • NCT03480646

    Phase 1/2, Completed, 175 people, Mar 29, 2018

  • NCT02158858

    Phase 1/2, Completed, 336 people, Jun 9, 2014